Special issue on Covid-19
  • Users Online: 73
  • Print this page
  • Email this page
Year : 2020  |  Volume : 17  |  Issue : 2  |  Page : 90-93

The dilemma of thymectomy in myasthenia gravis

1 Department of Neurology, Institute of Neurosciences, Indraprastha Apollo Hospitals, New Delhi, India
2 Attending Consultant, Critical Care, Max Super Speciality Hospital, New Delhi, India

Correspondence Address:
Pushpendra Nath Renjen
Institute of Neurosciences, Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi - 110 076
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/am.am_23_20

Rights and Permissions

Myasthenia gravis (MG) is an autoimmune disease that affects the neuromuscular junction causing fluctuating weakness of skeletal muscles. It is considered a rare disease with an estimated prevalence of 7.77/100,000. Surgical treatment is done by simple or extended thymectomy. Although thymectomy has been used in the treatment of MG since 1941, the role of thymectomy for MG is not completely understood. Perhaps, one of the longest unresolved issues in thoracic surgery is the role of thymectomy in the treatment of MG. Persistent questions and issues involve not only the surgical approach to thymectomy, but also the role of thymectomy itself in the treatment of MG. This article focuses on the review of thymectomy in MG patients.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal